Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Int J Cardiol ; 93(1): 87-8, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14729445

RESUMO

A case of uncontrolled hypertension with a vitreoretinal hemorrhage due to a retinal artery macroaneurysm of the right eye and chorio-retinal scars of the left eye as initial symptom of hypertension is presented. End organ damage was undiagnosed until an intraocular hemorrhage appeared in the right eye. The hemorrhage and retinal macroaneursym disappeared spontaneously with proper medical therapy for hypertension.


Assuntos
Aneurisma/etiologia , Hipertensão/complicações , Hemorragia Retiniana/etiologia , Bloqueadores dos Canais de Cálcio/uso terapêutico , Humanos , Hipertensão/tratamento farmacológico , Masculino , Pessoa de Meia-Idade
2.
Int J Cardiol ; 79(2-3): 223-9, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11461745

RESUMO

BACKGROUND: P-Selectin mediates adhesive interactions between platelets, leukocytes and endothelium to form thrombi. Our purpose was to investigate plasma soluble(s) P-selectin levels in patients with acute myocardial infarction (aMI) and the effect of thrombolysis on P-selectin levels. METHODS: Patients with aMI within the first 6 h of chest pain were enrolled prospectively. sP-selectin levels were determined by ELISA in the plasma of patients with aMI (n=32), stable angina (n=18), and healthy controls (n=15). Samples were obtained before, 3 and 24 h after reperfusion therapy with tissue plasminogen activator. Seven patients showed recurrent angina or failure to reperfuse. RESULTS: sP-selectin levels were significantly higher in aMI group than other groups (86.7+/-8.7 ng/ml, P<0.05). sP-selectin levels were similar in stable angina and control groups (28.8+/-4.4 vs. 25.4+/-7.3 ng/ml, P=NS). A significant increase in sP-selectin levels was observed 3 h after successful thrombolysis and this was followed by a decrease to near the baseline level late after reperfusion. But patients with failed reperfusion showed sustained high sP-selectin levels after 24 h of thrombolysis (P<0.05). CONCLUSION: The plasma sP-selectin level is elevated in aMI and it increases further following thrombolytic therapy. This increase is probably induced by activation of endothelial cells or platelets after myocardial ischemia and reperfusion during aMI. As the elevated levels are sustained in patients with failed reperfusion, serial P-selectin levels may be used as a non-invasive indicator of successful thrombolysis in aMI.


Assuntos
Monitoramento de Medicamentos , Infarto do Miocárdio/tratamento farmacológico , Selectina-P/efeitos dos fármacos , Terapia Trombolítica , Angina Pectoris/sangue , Biomarcadores , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/sangue , Infarto do Miocárdio/diagnóstico , Selectina-P/sangue , Estudos Prospectivos , Estatísticas não Paramétricas
3.
Ann Noninvasive Electrocardiol ; 6(2): 84-91, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11333164

RESUMO

BACKGROUND: The presence of ventricular late potentials (LP) is an important indicator for the development of ventricular tachyarrhythmias due to ischemic heart disease. The effect of myocardial revascularization on LP has remained controversial. The purpose of this study was to determine whether complete myocardial surgical revascularization (CABG) documented by myocardial perfusion scintigraphy might alter the substrate responsible for LP. METHODS: Prospectively, enrolled patients undergoing elective CABG were evaluated with thallium-201 myocardial perfusion scintigraphy and signal- averaged ECG pre- and postoperatively. SAECG recordings were obtained serially: before, 48-72 hours and 3 months after CABG. LPS were defined as positive if SAECG met at least two of Gomes criteria. Scintigraphies were performed pre- and 3 months postoperatively for determination of the success of revascularization. Changes observed in SAECG recordings after CABG were compared between those with and without successful revascularization. RESULTS: CABG resulted in successful revascularization in 23 patients and was unsuccessful in 17 (no change or deterioration of the perfusion defects). Preoperative SAECG values were not different between groups except for RMS values. The incidence of LP decreased significantly postoperatively in patients with improved myocardial perfusion, whereas there were no changes in patients who did not have postoperative perfusion improvement (McNemar test, P < 0.05). CONCLUSIONS: LPs disappear following the elimination of myocardial ischemia by complete surgical revascularization. Persistence of ischemia following CABG usually results in the persistence of late potentials. The incidence of ventricular arrhythmias is expected to be unchanged in these patients and they should be reevaluated for reinterventions.


Assuntos
Potenciais de Ação , Ponte de Artéria Coronária , Doença das Coronárias/diagnóstico por imagem , Doença das Coronárias/fisiopatologia , Eletrocardiografia , Processamento de Sinais Assistido por Computador , Tomografia Computadorizada de Emissão de Fóton Único , Função Ventricular Esquerda , Adulto , Idoso , Análise de Variância , Ponte de Artéria Coronária/métodos , Doença das Coronárias/etiologia , Doença das Coronárias/cirurgia , Eletrocardiografia/normas , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Estudos Prospectivos , Fatores de Risco , Radioisótopos de Tálio , Tomografia Computadorizada de Emissão de Fóton Único/normas , Resultado do Tratamento
4.
Am J Cardiol ; 83(7): 1135-7, A9, 1999 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-10190536

RESUMO

This randomized prospective clinical study evaluated the lipid-lowering effects and safety of a new combination regimen in patients with mixed hyperlipidemia. The data show that alternate-day simvastatin and fenofibrate therapy was as effective as the standard daily combination of the same drugs at the same doses, and it was safer, less expensive, and more tolerable.


Assuntos
Fenofibrato/administração & dosagem , Inibidores de Hidroximetilglutaril-CoA Redutases/administração & dosagem , Hiperlipoproteinemia Tipo V/tratamento farmacológico , Hipolipemiantes/administração & dosagem , Sinvastatina/administração & dosagem , Esquema de Medicação , Quimioterapia Combinada , Feminino , Fenofibrato/efeitos adversos , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/efeitos adversos , Hiperlipoproteinemia Tipo V/sangue , Hipolipemiantes/efeitos adversos , Lipídeos/sangue , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Sinvastatina/efeitos adversos
5.
Int Ophthalmol ; 23(1): 37-41, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-11008897

RESUMO

Electrocardiographic changes were investigated in 53 patients during subconjunctival drug injections. Decrease in heart-rate of more than 10% or arrhythmia was observed in 25 (47.2%) of the patients, who were considered to have a positive oculocardiac reflex. In the control group of 35 patients, only 3 (8.6%) were found to have a significant decrease in heart rate during blood sampling from antecubital vein (p = 0.000). Young age was a significant risk factor for oculocardiac reflex during injections (p = 0.01). Patient gender, verbal pain score, satiety, experience of periocular injections, injected drug type were not found to be risk factors. All patients with oculocardiac reflex were asymptomatic; however, it is still wise to have emergency supplies ready for any circulatory derangement during subconjunctival injections.


Assuntos
Aminoglicosídeos/efeitos adversos , Anti-Inflamatórios/efeitos adversos , Arritmias Cardíacas/induzido quimicamente , Túnica Conjuntiva/efeitos dos fármacos , Eletrocardiografia , Frequência Cardíaca/efeitos dos fármacos , Reflexo Oculocardíaco/efeitos dos fármacos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Aminoglicosídeos/administração & dosagem , Anti-Inflamatórios/administração & dosagem , Arritmias Cardíacas/fisiopatologia , Quimioterapia Combinada , Eletrocardiografia/efeitos dos fármacos , Endoftalmite/tratamento farmacológico , Feminino , Frequência Cardíaca/fisiologia , Humanos , Injeções , Masculino , Pessoa de Meia-Idade , Reflexo Oculocardíaco/fisiologia , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...